Vaginal Misoprostol Compared to Vaginal Dinoprostone for Induction of Labour: A Systematic Review and Meta‐Analysis
Open Access
- 19 August 2026
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Abstract
Introduction: Induction of labour is a common intervention. The prostaglandin dinoprostone is often used, but there is increasing evidence that misoprostol may be more effective without compromising safety. This review compares the efficacy and safety of vaginal misoprostol and vaginal dinoprostone. Methods: Electronic databases were searched for randomised controlled trials comparing singleton, term inductions with vaginal dinoprostone or vaginal misoprostol. The primary outcome was vaginal births within 24 h. Secondary outcomes included induction to birth interval, mode of birth, oxytocin augmentation, uterine hyperstimulation, fetal distress and adverse maternal and neonatal outcomes. A sub‐group analysis by misoprostol dosage (25 and ≥ 50 μg) was planned. A random effects meta‐analysis was performed and risk of bias assessed using Cochrane Risk of Bias 2 tool. Results: 44 papers reported 7040 participants induced with vaginal misoprostol and 6604 with vaginal dinoprostone. Participants given vaginal misoprostol were 48% (OR 1.48 95% CI 1.20, 1.84) more likely to achieve vaginal birth within 24 h, although heterogeneity was high. The rates of caesarean section, and adverse maternal or neonatal outcomes were comparable. In the vaginal misoprostol group, fewer patients required oxytocin (OR 0.51 95% CI 0.40, 0.65) and time to birth was reduced (−230 min (95% CI −286 to −175, I 2 57.6%)). These findings were consistent in the subgroup analysis, although uterine hyperstimulation with fetal heart rate changes was reduced in the 25‐μg group. Conclusion: Vaginal misoprostol is more effective for achieving vaginal birth in 24 h, reducing time to birth and oxytocin use when compared to vaginal dinoprostone. It does not seem to increase caesarean birth and has a similar side‐effect profile. At lower doses (25‐μg), it is likely to be similarly effective with a lower incidence of uterine hyperstimulation. This information can be used to support discussions around choice of induction agent.Keywords
This publication has 38 references indexed in Scilit:
- Methods of induction of labour: a network meta-analysisCochrane Database of Systematic Reviews, 2026
- Trustworthiness assessment as an inclusion criterion for systematic reviews—What is the impact on results?Cochrane Evidence Synthesis and Methods, 2023
- Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2021
- Low-dose oral misoprostol for induction of labourCochrane Database of Systematic Reviews, 2021
- A randomized controlled trial comparing low dose vaginal misoprostol and dinoprostone gel for labor inductionThe Journal of Obstetrics and Gynecology of India, 2011
- Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2010
- Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trialArchives of Gynecology and Obstetrics, 2008
- Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trialArchives of Gynecology and Obstetrics, 2007
- A randomized comparison between intravaginal misoprostol and prostaglandin E2 for labor inductionArchives of Gynecology and Obstetrics, 2006
- A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distressAmerican Journal of Obstetrics and Gynecology, 2004